ReviewPharmaceuticals (Basel, Switzerland)2025

Recent Preclinical Evidence on Phytocannabinoids in Neurodegenerative Disorders: A Focus on Parkinson's and Alzheimer's Disease.

Nicoleta-Mirela Blebea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.